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e 3, 2013.he purpose of this study was to analyze left ventricular obstruction in patients with hypertrophic cardiomyopathy
(HCM) during exercise echocardiography.Background Despite the association of symptoms with left ventricular outﬂow tract obstruction in HCM, there exist paradoxical
situations in which signiﬁcant intraventricular gradients (>50 mm Hg) at rest occur in conjunction with excellent
exercise tolerance.Methods To examine this phenomenon, we performed exercise echocardiography and analyzed the clinical status of
107 HCM patients with and without resting obstruction.Results At rest, 69 patients had no obstruction and 38 exhibited an intraventricular gradient, 9 of whom exhibited
a decrease in gradient of at least 30 mm Hg (99.4  35.5 mm Hg to 30.2  14.3 mm Hg, p < 0.001) during
exercise (paradoxical response to exercise [PRE]). The PRE patients presented with a signiﬁcantly lower New York
Heart Association clinical class and higher left ventricular volumes and arterial pressure both at rest and during
exercise than HCM patients in whom the gradient increased or did not change during stress echocardiography.
Finally, PRE patients exhibited a trend toward a reduced rate of cardiac events.Conclusions Our study reports a subgroup of HCM patients, designated PRE based on a decreased intraventricular gradient
during exercise. The reduced exertional obstruction may account for the better functional class and trend toward
fewer clinical events in PRE patients. (J Am Coll Cardiol 2013;62:842–50) ª 2013 by the American College of
Cardiology FoundationHypertrophic cardiomyopathy (HCM) is the most common
heritable cardiovascular disorder, affecting 0.2% to 0.5% of
the general population, and is a leading cause of sudden
cardiac death in young athletes (1). HCM is characterized by
an increased thickness of heart muscle, typically consisting of
asymmetric septal hypertrophy, and systolic anterior motion
(SAM) of the mitral valve. Resting left ventricular outﬂow
tract obstruction (LVOTO) due to SAM is observed in 25%
to 30% of HCM patients and, when severe, may cause
dyspnea, chest pain, syncope, and a predisposition to devel-
oping atrial arrhythmias (2).Centre Hospitalier Universitaire de Bordeaux,
ardiovascular Center, University of California at
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13; revised manuscript received May 28, 2013,Insights into the pathophysiology of LVOTO have
recently been provided by exercise echocardiography, which
can quantify the gradient during or after exercise (3–6).
Although the majority of HCM patients with resting
obstruction have increasing symptoms with exertion (3),
presumably in proportion to worsening LV obstruction,
some surprisingly do not. Despite the presence of resting
gradients exceeding 60 mm Hg in these unusual HCM
patients, they are unexpectedly often able to perform exercise
treadmill testing to levels of 150 W and greater.
On the basis of these clinical observations, we hypothe-
sized that some HCM patients may have a paradoxical
response to exercise (PRE), consisting of a decrease of
LVOTO during exercise that results in a preservation of
effort tolerance. Therefore, we conducted a prospective
exercise echocardiography study of HCM patients for whom
this procedure was scheduled for clinical indications. We
divided HCM patients into 2 subgroups, namely, patients
whose gradient either increased or did not signiﬁcantly
change and patients whose gradient decreased, and analyzed
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843the exercise tolerance, clinical status, and echocardiographic
measures of LV structure and function for the individual
subgroups.
Methods
From May 2009 to December 2011, 120 patients with
HCM were referred to evaluate functional capacity using
exercise echocardiography. The medical unit from which the
patients were drawn employs a specialized team, including
cardiac and genetic physicians, to manage >200 HCM
patients. This team keeps detailed clinical records for patient
management. The HCM was diagnosed by conventional
criteria (7,8). The study inclusion criteria were as follows: 1)
referral for exercise echocardiography; 2) previous formal
diagnosis of HCM based on both morphological hyper-
trophy and familial history; 3) sinus rhythm; and 4) ability to
perform bicycle exercise testing. Exclusion criteria were: 1)
poor ultrasonography window quality; and 2) recent history
of syncope, chest pain, or severe arrhythmia during exercise.
Information regarding the study and data collection was
provided to all patients, and the protocol was approved by
the institutional review board.
Resting echocardiography. Resting 2-dimensional (2D)
echocardiography was performed according to American
Society of Echocardiography guidelines (9,10), with ultra-
sound recordings obtained on a Vivid 9-dimension ultra-
sound system (General Electric Medical System, Horten,
Norway) by an experienced (level 3) operator (11).
Recordings in standardized views were acquired in 2D,
pulsed, continuous, and color Doppler modalities and stored
for subsequent analysis. Particular attention was paid to the
LVOT area to identify and analyze systolic anterior motion
of the mitral valve in both the parasternal long-axis and
apical 3- and 5-chamber views. After scanning the LVOT
with continuous wave Doppler, the maximal outﬂow velocity
was found and was measured. Outﬂow gradients were
automatically calculated from the ﬂow velocities using the
modiﬁed Bernoulli equation (12). Heart rate was calculated
at the time of gradient measurement based on the average of
3 R-R intervals.
Per-exercise echocardiography. The indications for exer-
cise echocardiography were as follows: evidence of latent
LVOTO in 64% of patients, clinical discordance between
symptoms and signs in 10%, evaluation of medical treatment
responses in 20%, and evaluation of mitral regurgitation
during effort in 6%. Functional status and blood pressure
adaptation during exercise were assessed in all patients.
Exercise echocardiography was performed without stopping
medications, according to the European Association of
Echocardiography guidelines (13), as bicycle exertion in a
semisupine position (50) with a slight left lateral tilt so as to
enable simultaneous transthoracic echocardiography during
exercise. Starting at 25W, thework loadwas increased by25W
every 2 min to the maximum tolerated effort. At each stage
from rest to recovery, electrocardiographic and conventionalechocardiography recordings in
2Dviews and continuous and color
Doppler modalities were acquired
and stored for of-ﬂine analysis.
Blood pressure was measured
using a cuff sphygmomanometer
at rest, at 1-min intervals during
exercise, and at 1-min intervals for
5 min during the recovery period
after exercise (14).
Echocardiography measurements.
An independent observer blin-
ded to patient history analyzed
all cases retrospectively, apply-
ing standard measurements ac-
cording to European Association
of Echocardiography/American
Society of Echocardiography
guidelines and using the internal
quantitation package of the echo-
cardiograph. Localization of hyper-
trophy was performed according to
the classiﬁcation of Maron et al.
(15). An estimate of LV mass was
obtained from theM-mode tracing.
TheLV and left atrial volumeswere
calculated from the apical 2- and 4-chamber views using
Simpson’s rule (9). Aortic and mitral velocities and velocity–
time integral were obtained using pulsed Doppler, and
pulmonary pressure was calculated from the measured
tricuspid gradient as (4 [tricuspid velocity (in m/s)]2) plus an
estimate of right atrial pressure from the inferior vena cava
(16). Filling pressures were estimated from the ratio of mitral
oriﬁce and septal annular early diastolic (E) velocities as E/E0
ratio. Longitudinal LV deformation with contraction was
obtained using the 2D speckle tracking method (17). The
length of the anterior mitral leaﬂet was measured from the
parasternal long-axis view during mid-diastole and with the
leaﬂet maximally extended as the distance from the junction
between the anterior leaﬂet and the posterior aortic wall to
the tip of the leaﬂet (18). Distance from SAM to the septum
as well as duration of mitral/septum contact when adequately
deﬁned were measured at rest and during exercise using
anatomic M-mode (19).
Because latent obstruction can occur at multiple LVOT
points, outﬂow velocities were measured using continuous
wave Doppler during exercise with the same direction and
angle as recorded at rest, and the highest outﬂow gradient
measured during the entire test was recorded. Speciﬁc
attention was paid so as not to confuse with mitral regur-
gitation ﬂow when present.
Medical history, other investigations, and cardiac events.
Each patient’s medical history was extracted from the
institutional database, including date of HCM diagnosis,
family history, symptoms and complications, pacemaker
implantation or heart surgery, and treatment at the time of
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844the study. Results of standardized cardiac magnetic reso-
nance imaging, 24-h Holter electrocardiography, and
biomarker parameters, such as B-type natriuretic peptide or
N-terminal pro–B-type natriuretic peptide, were also
extracted when available, provided that the tests were per-
formed within a year before exercise echocardiography.
Statistical analysis. All data were expressed as mean  SD,
and comparison was performed between subgroups using
Student’s unpaired t test for unpaired data and Fisher’s test
as appropriate. Independent variables of PRE were sought
using multiple linear regression analysis.
Results
Population characteristics. Speciﬁc data from this study
are provided in Tables 1 to 3. Of the 120 consecutive
patients with known HCM referred for exercise echocardi-
ography, 13 were excluded from analysis (7 for poor ultra-
sound window quality, 4 for atrial ﬁbrillation, and 2 New
York Heart Association [NYHA] functional class IV),
resulting in 107 HCM patients in the study group. Patient
characteristics are in Table 1. The mean age of the study
group at inclusion was 51.6  15.4 years, and their mean ageTable 1 Clinical Characteristics of Hypertrophic C
Clinical Characteristics at Rest
All Patients
(n ¼ 107)
Male 72 (67.3)
Age, yrs 51.6  15.4
Body surface area, g/m2 1.9  0.2
Age at diagnosis, yrs 43.4  18.5
Family history of HCM 53 (52)
Systolic blood pressure, mm Hg 129.5  20.8
Diastolic blood pressure, mm Hg 73.6  12
Heart rate, beats/min 67.1  12
NYHA functional class
Mean 1.7  0.6
I 42 (39.3)
I–II 5 (4.7)
II 50 (46.7)
III 10 (9.3)
Paroxysmal atrial ﬁbrillation 16 (15.1)
Chest pain 8 (7.5)
Sudden cardiac death 2 (1.9)
Syncope 26 (24.5)
Drugs
Beta-blockers 78 (72.9)
Verapamil 12 (11.2)
Disopyramide 2 (1.9)
ACEI or ARB 17 (15.9)
Amiodarone 9 (8.4)
Hypertension 13 (12.1)
Septal myectomy 4 (3.7)
Septal ablation 10 (9.3)
Dual-chamber pacemaker 5 (4.7)
Deﬁbrillator 23 (21.5)
Values are n (%) or mean  SD.
ACEI ¼ angiotensin-converting enzyme inhibitor; ARB ¼ angiotensin
nonobstructed; NS ¼ not signiﬁcant; NYHA ¼ New York Heart Association; Oat HCM diagnosis was 43.4  18.5 years. Mean NYHA
functional class was 1.7  0.6. Among these patients, 72.9%
were receiving beta-blockers, and 21.5% had undergone
implantable cardioverter-deﬁbrillator insertion in accordance
with guideline recommendations (7): 9% alcohol septal
ablation and 3.7% surgical septal reduction. Patient char-
acteristics of the individual subgroups are presented in
Table 1.
Resting echocardiographic measurements. The study
population’s mean maximal LV septal wall thickness was
21.1  4.9 mm (Table 2). Using criteria based on Doppler
measurements (i.e., outﬂow tract gradient exceeding
30 mm Hg), 38 (36%) patients had LVOT obstruction (OB)
at rest and 69 (64%) patients were nonobstructed (NOB).
The group with resting OB displayed a signiﬁcantly higher
maximal LV wall thickness than the NOB group (22.7  4.8
vs. 20.3  4.8, p ¼ 0.016). We also observed a greater
anterior mitral leaﬂet length associated with an increased
mitral valve regurgitation grade in the OB group compared
to the NOB group, as well as a larger left atrial volume.
Exercise testing. All exercise echocardiographic studies
were performed without complications; the primary reasonsardiomyopathy Patients
NOB Group
(n ¼ 69)
OB Group
(n ¼ 38) p Value
45 (65.2) 27 (71.1) NS
49.2  16.7 55.9  11.7 0.032
1.8  0.2 1.9  0.2 NS
42  19.1 45.8  17.3 NS
40 (60.6) 13 (36.1) 0.018
131.8  22.4 125.2  17.1 NS
74.2  12.4 72.5  11.2 NS
67.9  12.7 65.7  10.5 NS
1.6  0.6 1.9  0.7 0.008
32 (46.4) 10 (26.3) 0.042
3 (4.3) 2 (5.3) NS
31 (44.9) 19 (50) NS
3 (4.3) 7 (18.4) 0.038
9 (13.2) 7 (18.4) NS
3 (4.4) 5 (13.2) NS
2 (2.9) 0 (0) NS
15 (22.1) 11 (28.9) NS
46 (66.7) 32 (84.2) NS
9 (13) 3 (7.9) NS
1 (1.4) 1 (2.6) NS
10 (14.5) 7 (18.4) NS
5 (7.2) 4 (10.5) NS
10 (14.4) 3 (7.9) NS
3 (4.3) 1 (2.6) NS
2 (2.9) 8 (21.1) 0.007
2 (2.9) 3 (7.9) NS
12 (17.4) 11 (28.9) NS
II receptor blocker; HCM ¼ hypertrophic cardiomyopathy; NOB ¼
B ¼ obstructed.
Table 2
Echocardiographic Measurements at Rest in Hypertrophic Cardiomyopathy Patients
Without Obstruction Versus Patients With Obstruction
Echocardiographic Measurements at Rest
All Patients
(n ¼ 107)
NOB Group
n ¼ 69)
OB Group
(n ¼ 38) p Value
Maximal left ventricular wall thickness, mm 21.1  4.9 20.3  4.8 22.7  4.8 0.016
Asymmetry (IVSd/LWd) 2.1  0.8 2.1  0.9 2.1  0.5 NS
Anterior mitral leaﬂet length, mm 27.5  3.8 26.8  3.8 28.7  3.5 0.010
Mitral valve regurgitation grade 0.6  0.6 0.41  0.51 0.93  0.63 <0.001
LV maximal outﬂow tract gradient, mm Hg 31.0  34.6 10.3  5.8 68.8  33.2 <0.001
Maron class type
I 11 (10.3) 8 (11.6) 3 (7.9) NS
II 56 (52.3) 36 (52.2) 20 (52.6) NS
III 36 (33.6) 21 (30.4) 15 (39.5) NS
IV 4 (3.7) 4 (5.8) 0 (0) NS
Morphology
Septal inversion 61 (57.0) 38 (55.1) 23 (60.5) NS
Neutral 33 (30.8) 21 (30.4) 12 (31.6) NS
Apical 6 (5.6) 6 (8.7) 0 (0) NS
Sigmoid 7 (6.5) 4 (5.8) 3 (7.9) NS
LV end-diastolic volume, ml/m2 38.5  8.2 38.6  7.9 38.2  8.9 NS
LV end-systolic volume, ml/m2 11.4  3.9 11.5  3.8 11.2  4.1 NS
Biplane LV ejection fraction, % 70.5  7.2 70.2  7.9 70.9  5.7 NS
Global longitudinal strain, % 16.1  4.1 16.6  4.2 15.2  3.7 NS
Maximal biplane left atrial volume, ml/m2 35.3  19.3 30.5  16.6 44.2  20.9 <0.001
Doppler mitral inﬂow E/A velocities 1.2  0.6 1.3  0.6 1.1  0.4 NS
Mean E/E’ 12  5.8 10.6  4.5 15  7 0.001
S’ DTI right ventricle, cm/s 13.7  2.8 13.3  2.5 14.6  3.1 0.035
Values are n (%) or mean  SD.
DTI ¼ Doppler tissue imaging; E/A ¼ Mitral inﬂow E/A velocities; IVSd ¼ interventricular septum in diastole; LV ¼ left ventricular; LWd ¼ lateral wall
in diastole; Mean E/E’ ¼ Doppler mitral inﬂow E velocity to mitral annulus tissue E’ velocity; other abbreviations as in Table 1.
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845for exercise discontinuation were lower limb fatigue (73%)
and dyspnea (21%). One patient had atrial tachycardia
during exercise testing. Mean exercise performance level was
121  41 W, with a signiﬁcantly higher performance ach-
ieved in the group without resting obstruction as compared
to the obstructed group. Mean systolic blood pressures did
not differ at rest or during exercise between the NOB and
OB groups. Although no signiﬁcant difference in resting
heart rate was noted between the 2 groups, OB patients had
a lower exercise heart rate than NOB patients.
In the OB group (n ¼ 38), the maximal gradient increase
with exercise from 68.8  33.2 mm Hg to 78  58 mm Hg
was nonsigniﬁcant because of major differences in the
response of individual patients, as already described (20).
Based on the response to exercise, patients in the OB cohort
were divided into those who exhibited either a signiﬁcant
increase (>30 mm Hg [n ¼ 15, from 72  27 mm Hg to
138  45 mm Hg]) or no to minimal change (<30 mm Hg
[n ¼ 14, from 44  16 mm Hg to 43  19 mm Hg]) in
LVOT gradient (OBI group), and those in whom there
was a signiﬁcant decrease (>30 mm Hg [n ¼ 9, from 92.4 
59.4 mm Hg to 30.2  14.3 mm Hg]) in gradient (PRE
group) (Fig. 1, Table 3).
Relation to symptoms/exercise tolerance. The OB group
overall displayed a signiﬁcantly higher mean NYHA class
than the NOB group (1.9  0.7 vs. 1.6  0.6, p¼ 0.008), in
addition to a signiﬁcantly lower mean exercise tolerance (106 29 W vs. 129  45 W, p < 0.05). The majority of OB
patients (73.7%) were symptomatic (NYHA class >1).
Within the OB group, a signiﬁcantly better mean NYHA
class was observed in the PRE subgroup compared to the
OBI subgroup (1.4  0.5 vs. 2.1  0.7, p ¼ 0.009), as was
a numerically but not signiﬁcantly higher maximal exercise
load (115  30 W vs. 103  28 W, p ¼ NS). Systolic blood
pressures were signiﬁcantly higher at rest and during exercise
in the PRE than in the OBI patients. The average increases
in LVOT gradient from rest to exercise for patients with
NYHA class I, II, and III were 4.3  40 mm Hg, 20  46
mm Hg, and 29  24 mm Hg, respectively (p < 0.05
between NYHA class I and II). However, no correlation was
found between NYHA class and the magnitude of increase
of gradient with exercise.
Cardiac structure and function. At rest, the PRE group
exhibited signiﬁcantly higher end-diastolic and end-systolic
LV volumes (43.8  7.5 ml/m2 vs. 36.3  8.6 ml/m2,
and 14.4  3.8 ml/m2 vs. 10.2  3.6 ml/m2, respectively;
both, p < 0.05), and a numerically but not signiﬁcantly
lower ejection fraction compared to the OBI patients
(Table 3). The LV mass and longitudinal contraction were
similar for these cohorts. Regarding diastolic function, only
Doppler mitral inﬂow E/A velocities ratio statistically
differed between the 2 groups. Finally, LVOTO was
higher in the PRE group (99.4  35.5 mm Hg vs. 59.2 
26.4 mm Hg, p¼ 0.003) despite a shorter anterior mitral
Table 3
Paradoxical Response to Exercise Patients Versus Obstructive Hypertrophic
Cardiomyopathy at Rest With Increased Gradient or No Change During Exercise
Patients at Rest and During Exercise
OBI Patients
(n ¼ 29)
PRE Patients
(n ¼ 9) p Value
Male 20 (69) 7 (77.8) NS
Age, yrs 53.7  11.9 62.8  8.2 0.044
Age at diagnosis, yrs 42.5  17.5 57.6  10.6 0.025
NYHA functional class 2.1  0.7 1.4  0.5 0.009
At rest
Systolic blood pressure, mm Hg 121.1  14.5 140  18.8 0.016
Diastolic blood pressure, mm Hg 69.7  10.4 83.9  6.0 0.003
Heart rate, beats/min 65.7  10.0 65.4  12.7 NS
Maximal LV wall thickness, mm 23.2  4.7 20.8  4.9 NS
Asymmetry (IVS/PW) 2.2  0.6 1.7  0.3 0.012
Anterior mitral leaﬂet length, mm 29.7  3.4 25.6  1.2 <0.001
Mitral valve regurgitation grade 1.0  0.6 0.8  0.7 NS
LVOT gradient, mm Hg 59.2  26.4 99.4  35.5 0.003
Mitral valve/septum distance, mm 1.3  3.7 1.1  2.7 NS
Duration of mitral valve/septum contact, ms 81.1  56.7 94.1  64.5 NS
LV end-diastolic volume, ml/m2 36.3  8.6 43.8  7.5 0.026
LV end-systolic volume, ml/m2 10.2  3.6 14.4  3.8 0.006
Biplane LV ejection fraction, % 72.0  5.4 67.4  5.1 0.031
Global longitudinal strain, % 15.3  3.9 14.9  3.2 NS
Maximal biplane left atrial volume, ml/m2 83.7  44.1 82.1  34.4 NS
Doppler mitral inﬂow E/A velocities 1.2  0.5 0.8  0.2 0.009
Mean E/E’ 14.8  6.8 16.0  8.4 NS
Exercise
Maximal charge, W 103  28 115  30 NS
Percentage of calculated maximal heart rate, % 70.6  14.8 68.7  10.8 NS
Systolic blood pressure increase >20 mm Hg 20 (71.4) 9 (100) NS
Peak systolic blood pressure, mm Hg 151.7  26.4 191.8  22.9 0.001
Peak diastolic blood pressure, mm Hg 63.4  24.2 86.7  25.1 0.026
Peak heart rate, beats/min 113.6  23.4 108.9  13.6 NS
Mitral valve regurgitation grade 1.0  0.6 0.4  0.5 0.032
Mitral valve/septum distance, mm 1.5  3.4 7.8  3.2 0.001
Duration of mitral valve/septum contact, ms 77.6  61.7 0  0 0.001
LVOT gradient, mm Hg 92.4  59.4 30.2  14.3 0.004
LV end-diastolic volume, ml/m2 33.2  8.6 44.1  8.5 0.022
LV end-systolic volume, ml/m2 9.7  2.8 12.2  2.9 0.009
Biplane LV ejection fraction, % 69.8  8.3 72.4  4.0 NS
Values are n (%) or mean  SD.
IVS/PP ¼ inverventricular septum to posterior wall thiknesses ratio; LVOT ¼ left ventricular outﬂow tract; OBI ¼ obstructive hypertrophic
cardiomyopathy at rest with increased gradient or no change during exercise; PRE ¼ paradoxical response to exercise; other abbreviations as in
Tables 1 and 2.
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846valve (25.6 1.2 mm vs. 29.7 3.4 mm, p< 0.001). At rest,
mitral to septum distance and duration of mitral contact to
septum were similar in the 2 groups (respectively, 1.1 
2.7 mm vs. 1.3  3.7 mm, p ¼ NS; and 94.1  64.5 ms vs.
81.1 56.7 ms, p¼NS). Interestingly, at-rest systolic blood
pressure was higher in the PRE group (140 18.8mmHg vs.
121.1  14.5 mm Hg, p ¼ 0.016), whereas heart rates were
numerically but not signiﬁcantly less than in the OBI group.
During exercise, mean gradients at peak exercise were
30.2  14.3 mm Hg and 92.4  59.4 mm Hg for the PRE
and OBI patients, respectively (p ¼ 0.004), and 140  70
mm Hg and 114  69 mm Hg in the ﬁrst 30 s during
recovery, respectively (p ¼ 0.32). From rest to exercise,mitral to septum distance signiﬁcantly increased in the PRE
group (from 1.1  2.7 mm to 7.8  3.2 mm, p < 0.01) but
not in the OBI group (p < 0.001 between groups). Duration
of mitral contact to septum was similar in the OBI group
(from 81.1  56.7 ms to 77.6  61.7 ms, p ¼ NS) but was
no longer present in the PRE group (p < 0.001 between
groups).
Patients reached 68.7% and 70.6% (p ¼ NS) of maximal
heart rate in the PRE group and the OBI group, respec-
tively, with a trend toward higher exercise workload in the
PRE group (115  30 W vs. 103  28 W; p ¼ NS).
Systolic blood pressure during exercise was signiﬁcantly
higher in the PRE group, with a signiﬁcantly higher
Figure 1 Example of a Paradoxical Response to Exercise
In this asymptomatic hypertrophic cardiomyopathy patient with a resting obstruction of 82 mm Hg (A ¼ continuous Doppler ﬂow, B ¼ M-mode tracing), a decrease of obstruction
to 43 mm Hg was observed during exercise, resulting in excellent exercise tolerance (150 W) (C ¼ continous Doppler ﬂow; D ¼ M-mode tracing). Grd ¼ gradient.
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847systolic blood pressure increase during exercise (38  10%
vs. 25  17%, p < 0.05) in the PRE group. At peak
exercise, PRE patients exhibited higher end-diastolic LV
volume and end-systolic LV volume (44.1  8.5 ml/m2 vs.
33.2  8.6 ml/m2, and 12.2  2.9 ml/m2 vs. 9.7  2.8 ml/m2,
respectively; both, p < 0.05). Importantly, in the PRE group,
exercise resulted in a signiﬁcant reduction in end-systolic
LV volume, with maintained end-diastolic LV volume.
In the OBI group, these parameters remained unchanged
during exercise. Thus, there was a trend toward higher
ejection fraction levels in the PRE group (72.4  4.0% vs.
69.8  8.3%), but the between-group differences did not
reach statistical signiﬁcance, showing a correct adaptation
of LV function.
Retrospective data. RELATION TO PATIENTS’ HISTORY AND
CARDIAC EVENTS (N [ 107). Regarding HCM history (follow-
up duration: 10.4  9.4 years), a positive diagnosis was
established at a more advanced age in the PRE group
compared to theOBI group (57.6 10.6 years vs. 42.5 17.5
years, p ¼ 0.025), which was associated with late symptoms
and a lower functional NYHA class (1.4  0.5 vs. 2.1  0.7,p ¼ 0.009). Similarly, the death risk criteria sum (premature
HCM-related sudden death of 1 relatives; history of unex-
plained syncope judged inconsistent with neurocardiogenic
origin; multiple and/or prolonged runs of nonsustained
ventricular tachycardia on serial 24-h ambulatory Holter
electrocardiographic monitoring at heart rates 120 beats/
min; hypotensive or attenuated blood pressure response to
exercise; and massive left ventricular hypertrophy [21]) was
numerically lower in the PRE group (0.5  0.7 vs. 1.0  1.1,
p ¼ NS), with 11% of PRE patients having undergone
implantable cardioverter-deﬁbrillator insertion versus 34% of
other OB patients.
HEART MORPHOLOGY FROM MRI. In total, 31 of 38 OB
patients (81%) underwent MRI examination. In the PRE
group, there was a trend toward higher end-diastolic LV
volume as compared to OBI patients (129  63 vs. 114 
32, p ¼ 0.2), along with a signiﬁcantly lower maximum wall
thickness (19  2 mm vs. 23  5 mm, p < 0.05). Late
enhancement was found in 50% of PRE patients versus 75%
of OBI patients.
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Since the ﬁrst demonstration of a relationship between the
degree of LV obstruction and prognosis in HCM patients,
interest in understanding the pathophysiology of this
phenomenon has grown (22). Provoked latent obstruction
has been invoked as a major cause of exercise intolerance (6).
We analyzed 107 HCM cases referred for stress echocar-
diography, and identiﬁed a previously unappreciated
response of LV obstruction to exertion characterized by
a progressive decrease in LVOT gradient from rest to peak
exercise. This phenomenon was observed in 8% of our
HCM patients overall, and 23% of those with resting
obstruction >30 mm Hg. We have referred to this
phenomenon as paradoxical response to exercise (PRE),
highlighting the unexpected reduction in gradient with
exertion in HCM patients. This pattern of response to
exertion was associated with trends toward a greater exer-
tional capacity and a superior NYHA functional class.
Exercise echocardiography in HCM and PRE. Num-
erous recent publications have already addressed the ques-
tions of prevalence, signiﬁcance, origin, and consequences of
LVOTO during exercise in HCM, comparing patients
without obstruction at rest with those presenting signiﬁcant
gradients before exercise testing. Different types of “stressors”
have been evaluated, including pharmacological stimulation,
Valsalva maneuvers, and exercise tests (23). Most studies
investigating dynamic obstruction focused on conventional
treadmill exercise followed by echocardiographic recordings
at recovery (3–5,24,25). This approach cannot be considered
to be a pure evaluation of exercise dynamics, as dramatic pre-
load variations are observed a few seconds after the end of
effort, especially when using a bicycle test. When upright, at
the end of lower limb muscle exercise, there is a large decrease
in venous blood return to the heart, yielding: 1) decreased LV
volume; 2) decreased wall stress; 3) continued sympathetic
drive; and 4) a hyperkinetic state like that observed during
dobutamine-induced stress. Indeed, dobutamine infusion
has been shown to generate obstructions independently of
HCM (26,27), as can the post-exercise test (20).
In our study, we used bicycle exercise, simulating day-to-
day exertional provocation and allowing for real-time screening
of hemodynamics throughout the evaluation. Consequently,
our ﬁndings are not fully comparable to those of immediate
post–upright exercise studies. This crucial difference may also
explain why other researchers have not previously described
PRE in their series. However, 3 recent publications reported
exercise studies. Shah et al. (4) and Nistri et al. (28) reported
latent obstruction in 60% and 40% of patients, respectively;
they were not able to observe any PRE, as resting obstruction
was an exclusion criterion. The most recent study, by Jensen
et al. (23), evaluated patients treated with septal myocardial
ablation. Except for 7 patients, none of the others exhibited
a resting gradient. During exercise, the gradient in these
7 patients increased to an average of 66 mm Hg.Mechanisms of LV obstruction in HCM and PRE. Al-
though the Venturi effect was believed to be responsible for
SAM (4,29,30), the most recent evidence for LV obstruction
inHCMpatients favors the ﬂow drag mechanism causing the
mitral valve to be pushed against the septum (7). The mech-
anism of obstruction is probably also related to other alter-
ations produced by HCM. Experimental and observational
data suggest that anterior displacement of the papillary
muscles and submitral apparatus is necessary to create sufﬁ-
cient leaﬂet slack to allow for anterior motion of the mitral
leaﬂet (31,32). Nevertheless, the major potential effects of
ventricular loading and myocardial contractility must also be
considered. These effects may be exerted both in early systole,
for which ﬂow, drag, and pushing force of ﬂow are the
dominant hydrodynamic forces for SAM, and at midsystole,
for which the displacing force is more prominent (5). Hence,
small variations in preload, afterload, or contractility, such as
produced by exertion, may lead to large changes in gradient,
usually explaining the ampliﬁcation of obstruction from rest to
exercise or from exercise to recovery. Surprisingly, in a small
group of patients, we observed an unexpected and signiﬁcant
decrease in the obstruction from rest to exercise, described
here as PRE. The LVOTO decrease was associated with
reduction in SAM (Fig. 1).
Comparisons of OBI and PRE patient groups revealed
that load conditions signiﬁcantly differed between the 2
patient groups. Notably end-diastolic LV volume and
systolic blood pressure were greater both at rest and during
exercise in PRE. We also observed more pronounced
changes in these parameters from rest to exercise in the PRE
group. Differences in mitral-septal contact accompanied
these ﬁndings. These observations are consistent with the
concept that speciﬁc characteristics of ventricular loading
both at rest and during exertion may be responsible for the
decrease in LVOTO with exercise. It is possible that the
larger LV volumes may predispose to a decrease in
obstruction because there is less slack in the submitral
apparatus. Similarly, the decrease in systolic volume may be
related to the reduction of the LVOTO.
Safety and prognosis. Although this study was not
designed to prospectively evaluate the risk for complications
in our HCM patient group, we retrospectively examined
patients’ records from our local database. Surprisingly, we
observed a lower rate of recorded abnormalities, adverse
events, and medical interventions such as implantable
cardioverter-deﬁbrillator insertion or septal ablation in the
PRE patients. However, statistically signiﬁcant levels were
not achieved for all criteria, probably because of the limited
size of the PRE group. Nonetheless, our ﬁndings demon-
strate that exercise echocardiography in HCM patients with
resting obstruction may be useful in identifying a subgroup
of patients with a lesser risk of complications. The data also
suggest that the effects on exertional capacity of pharma-
cologic agents should be tested in individual HCM patients,
as these agents may potentially exert detrimental effects,
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previous data indicating the safety of exercise echocardiog-
raphy in HCM patients, even in the presence of signiﬁcant
obstruction at rest (33,34).
Study limitations. The sample size of our study was
limited, reﬂecting the clinical prevalence of HCM. Our
study was not designed to assess the prevalence of PRE in
HCM patients, as we included only patients referred to our
echocardiography department for exercise echocardiography.
Therefore, the proportion of PRE patients observed in our
study cannot be extrapolated to the whole HCM population.
We did not use objective means such as oxygen consumption
(VO2) to quantify exercise capacity, and the examiners were
not blinded during the performance of the stress test. The
patients were evaluated in a semisupine position, which is
not similar to treadmill exercise testing. Theoretically, PRE
might be more common with exercise treadmill echocardi-
ography as the patient is placed supine at termination and
venous return may be augmented even more than with
upright bike exercise, which is consistent with a better
NYHA class in PRE during their routine life. Finally, as this
is a retrospective study, we cannot establish a causal rela-
tionship between the response of the LVOT gradient to
exercise and symptomatic status.
Conclusions
Left ventricular outﬂow obstruction is a central feature of the
pathophysiology of hypertrophic cardiomyopathy, and is
believed to increase during exercise with an attendant
production of symptoms. This report describes a possible
subgroup of HCM patients in whom a high resting gradient
was reduced during exertion. This response was associated
with a trend toward increased exertional capacity and
functional class, fewer complications, and a more physio-
logical proﬁle of LV structure and function. If these ﬁndings
are conﬁrmed in larger studies, they may have important
implications for patient management.
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